electroCore Inc., a bioelectronic technology company, has partnered with Acacia Clinics and the Vagus Nerve Society to launch a new research initiative investigating the use of electroCore’s gammaCore Sapphire, a non-invasive vagus nerve stimulator (nVNS), as an adjunctive treatment for symptoms associated with post-traumatic stress disorder (PTSD). The study will enroll up to 40 participants diagnosed with PTSD and is expected to run for 10 months. electroCore will provide an educational grant and gammaCore Sapphire devices, while the Vagus Nerve Society will sponsor the study. The research aims to assess both the safety and effectiveness of nVNS for PTSD symptom relief.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. electroCore Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9629029) on January 21, 2026, and is solely responsible for the information contained therein.